78 related articles for article (PubMed ID: 6539614)
1. On the pharmacokinetics of latamoxef in normal and impaired renal function.
Höffler D; Koeppe P; Moecke D
Arzneimittelforschung; 1984; 34(3):317-20. PubMed ID: 6539614
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of ceftazidime in normal and impaired renal function.
Höffler D; Koeppe P; Williams KJ
Arzneimittelforschung; 1984; 34(1):72-6. PubMed ID: 6367755
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of Cefmenoxime in normal and impaired renal function.
Höffler D; Koeppe P
Arzneimittelforschung; 1983; 33(2):269-72. PubMed ID: 6303362
[TBL] [Abstract][Full Text] [Related]
4. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
Kirch W; Köhler H; Berggren G; Braun W
Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.
Welink J; Boven E; Vermorken JB; Gall HE; van der Vijgh WJ
Clin Cancer Res; 1999 Sep; 5(9):2349-58. PubMed ID: 10499604
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics of nimodipine in normal and impaired renal function.
Kirch W; Rämsch KD; Dührsen U; Ohnhaus EE
Int J Clin Pharmacol Res; 1984; 4(5):381-4. PubMed ID: 6519852
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of aspoxicillin in subjects with normal and impaired renal function.
Geyer J; Höffler D; Koeppe P
Arzneimittelforschung; 1988 Nov; 38(11):1635-9. PubMed ID: 3214450
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of glucarpidase in subjects with normal and impaired renal function.
Phillips M; Smith W; Balan G; Ward S
J Clin Pharmacol; 2008 Mar; 48(3):279-84. PubMed ID: 18192538
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics of intravenous mezlocillin in patients with normal and impaired renal function (author's transl)].
Cano JP; Rigault JP; Gevaudan MJ; Saingra S; Murisasco A; Charpin J
Nouv Presse Med; 1982 Feb; 11(5 Pt 2):335-9. PubMed ID: 6460972
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of azlocillin in healthy subjects.
Leroy A; Humbert G; Fillastre JP
Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic studies on clavulanate potentiated ticarcillin in normal subjects and patients with renal insufficiency.
Koeppe P; Höffler D; Hulla FW
Arzneimittelforschung; 1987 Feb; 37(2):203-8. PubMed ID: 3580024
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic study of memantine in healthy and renally impaired subjects.
Periclou A; Ventura D; Rao N; Abramowitz W
Clin Pharmacol Ther; 2006 Jan; 79(1):134-43. PubMed ID: 16413248
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of ticarcillin in patients with normal and impaired renal function (author's transl)].
Höffler D; Dalhoff A; Koeppe P
Dtsch Med Wochenschr; 1978 Jun; 103(22):931-5. PubMed ID: 350535
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intravenous, single-dose tiotropium in subjects with different degrees of renal impairment.
Türck D; Weber W; Sigmund R; Budde K; Neumayer HH; Fritsche L; Rominger KL; Feifel U; Slowinski T
J Clin Pharmacol; 2004 Feb; 44(2):163-72. PubMed ID: 14747425
[TBL] [Abstract][Full Text] [Related]
16. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.
Hoek FJ; Kemperman FA; Krediet RT
Nephrol Dial Transplant; 2003 Oct; 18(10):2024-31. PubMed ID: 13679476
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function.
Moellering RC; Krogstad DJ; Greenblatt DJ
Rev Infect Dis; 1981; 3 suppl():S230-5. PubMed ID: 7342286
[TBL] [Abstract][Full Text] [Related]
19. Pentostatin pharmacokinetics and dosing recommendations in patients with mild renal impairment.
Lathia C; Fleming GF; Meyer M; Ratain MJ; Whitfield L
Cancer Chemother Pharmacol; 2002 Aug; 50(2):121-6. PubMed ID: 12172976
[TBL] [Abstract][Full Text] [Related]
20. Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function.
Spruill WJ; Wade WE; Cobb HH
Am J Geriatr Pharmacother; 2008 Aug; 6(3):153-60. PubMed ID: 18775390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
